Literature DB >> 2060877

Natural history of hepatic haemangiomas: clinical and ultrasound study.

L Gandolfi1, P Leo, L Solmi, E Vitelli, G Verros, A Colecchia.   

Abstract

Hepatic haemangiomas are the most common benign tumours of the liver and commonly present as incidental findings on sonographic examination of the abdomen. Since little is known of the natural course of these tumours, we performed a clinical and sonographic follow up of 123 haemangioma patients. Our prospective study investigated clinical and sonographic findings in 158 haemangiomas for periods of 12 to 60 months. Ninety nine haemangiomas measured less than 2 cm and had an echogenic pattern; 40 were between 2 cm and 5 cm with a mainly echogenic structure; 19 measured greater than 5 cm and showed a mixed echo pattern. At the first examination only eight patients, all with giant haemangiomas, presented symptoms which could be attributed to the tumour. During follow up only one haemangioma changed in shape and size. One patient who was symptom free at the first examination experienced right upper abdominal quadrant pain during follow up. No deterioration occurred in any of the patients with symptoms at the first examination, and all had a satisfactory quality of life. No complications arose during the follow up period. This study shows that in adults haemangiomas remain stable in size and echo patterns rarely change. Only haemangiomas greater than 5 cm may cause symptoms. Prolonged clinical and sonographic follow up of small and medium sized haemangiomas is not warranted.

Entities:  

Mesh:

Year:  1991        PMID: 2060877      PMCID: PMC1378888          DOI: 10.1136/gut.32.6.677

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Cavernous hemangioma of the liver.

Authors:  J L OCHSNER; B HALPERT
Journal:  Surgery       Date:  1958-04       Impact factor: 3.982

2.  Hemangioma of the liver; special reference to its association with cysts of the liver and pancreas.

Authors:  M FELDMAN
Journal:  Am J Clin Pathol       Date:  1958-02       Impact factor: 2.493

3.  Benign tumors of the liver. II. Hemangiomas.

Authors:  M B DOCKERTY; H K GRAY; S W HENSON
Journal:  Surg Gynecol Obstet       Date:  1956-09

4.  [Does arterial embolization have a role in the treatment of cavernous hemangioma of the liver in adults?].

Authors:  B Martin; A Roche; L Radice; K Aguilar; C Kraiem
Journal:  Presse Med       Date:  1986-06-07       Impact factor: 1.228

5.  Cavernous hemangioma of the liver: ultrasonography, arteriography, and computed tomography.

Authors:  P C Freeny; T R Vimont; D C Barnett
Journal:  Radiology       Date:  1979-07       Impact factor: 11.105

6.  Enlargement of cavernous haemangioma associated with exogenous administration of oestrogens.

Authors:  J E Morley; J B Myers; F S Sack; F Kalk; E E Epstein; J Lannon
Journal:  S Afr Med J       Date:  1974-04-06

7.  Solitary echogenic spot in the liver: is it diagnostic of a hemangioma?

Authors:  R L Bree; R E Schwab; H L Neiman
Journal:  AJR Am J Roentgenol       Date:  1983-01       Impact factor: 3.959

8.  An incidental hemangioma of the liver: the dilemma of patient management.

Authors:  C R Taylor; K J Taylor
Journal:  J Clin Gastroenterol       Date:  1981-03       Impact factor: 3.062

9.  Sonographically detected hepatic hemangiomas: absence of change over time.

Authors:  R G Gibney; A P Hendin; P L Cooperberg
Journal:  AJR Am J Roentgenol       Date:  1987-11       Impact factor: 3.959

10.  Surgical treatment of giant hemangioma of the liver.

Authors:  Y Kawarada; R Mizumoto
Journal:  Am J Surg       Date:  1984-08       Impact factor: 2.565

View more
  49 in total

1.  CT and MRI findings correlate with the time-course of unresectable cavernous haemangioma of the liver after fractionated radiotherapy.

Authors:  H-L Lee; T-S Chung; S-W Chen; W T Lao
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

2.  Enucleation of centrally located giant hepatic hemangioma: report of two cases.

Authors:  Selcuk Mevlut Hazinedaroglu; Huseyin Ayhan Kayaoglu; Mehmet Ali Yerdel
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

3.  Giant hepatic hemangioma masquerading as a gastric subepithelial tumor.

Authors:  Rajan Kochar; Muslim Atiq; Jeffrey H Lee; Gene Landon; Paul F Mansfield; Manoop S Bhutani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

4.  Surgical Management for Giant liver Hemangiomas Greater Than 20 cm in Size.

Authors:  Hui Jiang; Zheyu Chen; Pankaj Prasoon; Hong Wu; Yong Zeng
Journal:  Gut Liver       Date:  2011-06-28       Impact factor: 4.519

5.  Painful hepatic hemangioma: report of a case with an emphasis on sonographic findings.

Authors:  Ryusuke Kato; Hideaki Ishida; Hitoshi Yagisawa; Toru Ishii; Tomoya Komatsuda; Takaharu Miyauchi; Tsutomu Sato; Ken Saito
Journal:  J Med Ultrason (2001)       Date:  2009-10-28       Impact factor: 1.314

6.  Sonographic characterization of 271 hepatic hemangiomas with typical appearance on CT imaging.

Authors:  Hiroaki Ito; Fumio Tsujimoto; Yasuo Nakajima; Gaku Igarashi; Takanori Okamura; Masaru Sakurai; Sachihiko Nobuoka; Takehito Otsubo
Journal:  J Med Ultrason (2001)       Date:  2012-01-12       Impact factor: 1.314

7.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

Authors:  Jennifer Guy; Marion G Peters
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

8.  Hepatobiliary Quiz Answers-19 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-10-03

Review 9.  Benign solid tumors of the liver: management in the modern era.

Authors:  Georgios Antonios Margonis; Aslam Ejaz; Gaya Spolverato; Neda Rastegar; Robert Anders; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

10.  Hepatic cavernous hemangioma in cirrhotic liver: imaging findings.

Authors:  J S Yu; K W Kim; M S Park; S W Yoon
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.